Literature DB >> 20189732

Infant autonomic functioning and neonatal abstinence syndrome.

Lauren M Jansson1, Janet A Dipietro, Andrea Elko, Martha Velez.   

Abstract

BACKGROUND: Neonatal abstinence syndrome (NAS) expression is widely variable among affected infants and the reasons for this variability are largely unknown; mechanisms that predispose infants to NAS expression are not understood. It has been postulated that the regulatory problems of prenatally drug exposed infants are manifested in dysfunctional vagal regulation of autonomic processes. The current study examines whether cardiac vagal tone, an indicator of parasympathetic neuroregulation, provides a marker for autonomic dysregulation subsequently expressed as NAS in prenatally opioid-exposed newborns.
METHODS: Heart period (HP) and cardiac vagal tone (V) were derived from electrocardiogram data collected from 64 methadone-exposed infants on postnatal days 1 and 3. The postpartum NAS course was assessed serially.
RESULTS: Infants with lower V on day 1 had significantly higher NAS symptomatology on day 3. Boys had more severe NAS symptoms than girls through the first 4 days of life and, among infants receiving pharmacologic treatment for NAS, boys required longer treatment course and hospitalizations. Greater poly-drug exposure, detected through toxicology screening throughout pregnancy, and cocaine use in particular, were associated with lower V and shorter HP (faster heart rate) in newborns. Multiple regression models accounted for 25-35% of the variance in NAS symptoms and duration of hospitalization in methadone-exposed infants. Significant predictors included infant sex, SSRI/SNRI use, and cigarette smoking.
CONCLUSIONS: Results support the hypothesis of a biologic vulnerability of autonomic regulatory functioning in methadone-exposed infants and greater male infant vulnerability to maternal methadone use. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189732      PMCID: PMC2875284          DOI: 10.1016/j.drugalcdep.2010.01.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

1.  Racial and gender differences in the viability of extremely low birth weight infants: a population-based study.

Authors:  Steven B Morse; Samuel S Wu; Changxing Ma; Mario Ariet; Michael Resnick; Jeffrey Roth
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

2.  Fetal response to maternal methadone administration.

Authors:  Lauren M Jansson; Janet Dipietro; Andrea Elko
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

3.  High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.

Authors:  John J McCarthy; Martin H Leamon; Michael S Parr; Barbara Anania
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

4.  Prenatal development of intrafetal and maternal-fetal synchrony.

Authors:  Janet A DiPietro; Laura E Caulfield; Rafael A Irizarry; Ping Chen; Mario Merialdi; Nelly Zavaleta
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

5.  The effect of maternal methadone use on the fetal heart pattern: a computerised CTG analysis.

Authors:  R Navaneethakrishnan; S Tutty; C Sinha; S W Lindow
Journal:  BJOG       Date:  2006-08       Impact factor: 6.531

Review 6.  The polyvagal perspective.

Authors:  Stephen W Porges
Journal:  Biol Psychol       Date:  2006-10-16       Impact factor: 3.251

Review 7.  Serotonin reuptake inhibitor-induced perinatal complications.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

8.  Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.

Authors:  Lauren M Jansson; Janet A Dipietro; Andrea Elko; Martha Velez
Journal:  J Matern Fetal Neonatal Med       Date:  2007-09

9.  Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.

Authors:  Lucy Burns; Richard P Mattick
Journal:  Drug Alcohol Rev       Date:  2007-09

10.  Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

Authors:  Rachel Levinson-Castiel; Paul Merlob; Nehama Linder; Lea Sirota; Gil Klinger
Journal:  Arch Pediatr Adolesc Med       Date:  2006-02
View more
  30 in total

1.  Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis.

Authors:  Kathryn Dee L MacMillan; Cassandra P Rendon; Kanak Verma; Natalie Riblet; David B Washer; Alison Volpe Holmes
Journal:  JAMA Pediatr       Date:  2018-04-01       Impact factor: 16.193

2.  Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers.

Authors:  Hendrée E Jones; Krisanna Deppen; Mark L Hudak; Lisa Leffert; Carol McClelland; Leyla Sahin; Jacquelyn Starer; Mishka Terplan; John M Thorp; James Walsh; Andreea A Creanga
Journal:  Am J Obstet Gynecol       Date:  2013-10-10       Impact factor: 8.661

3.  The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.

Authors:  David Knoppert
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

Review 4.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

5.  Autonomic nervous system functioning assessed during the Still-Face Paradigm: A meta-analysis and systematic review of methods, approach and findings.

Authors:  Karen Jones-Mason; Abbey Alkon; Michael Coccia; Nicole R Bush
Journal:  Dev Rev       Date:  2018-09-24

Review 6.  Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.

Authors:  Davida M Schiff; Matthew R Grossman
Journal:  Semin Fetal Neonatal Med       Date:  2019-01-28       Impact factor: 3.926

7.  In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.

Authors:  Bryce A Griffin; Caitlin O Caperton; Lauren N Russell; Christian V Cabanlong; Catheryn D Wilson; Kyle R Urquhart; Bradford S Martins; Marcelle Dina Zita; Amy L Patton; Alexander W Alund; S Michael Owens; William E Fantegrossi; Jeffery H Moran; Lisa K Brents
Journal:  J Pharmacol Exp Ther       Date:  2019-04-26       Impact factor: 4.030

8.  Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.

Authors:  Hendrée E Jones; Sarah H Heil; Michelle Tuten; Margaret S Chisolm; Julianne M Foster; Kevin E O'Grady; Karol Kaltenbach
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

9.  Developmental Outcomes of Infants Adopted from Foster Care: Predictive Associations from Perinatal and Preplacement Risk Factors.

Authors:  Irene Tung; Allison S Christian-Brandt; Audra K Langley; Jill M Waterman
Journal:  Infancy       Date:  2019-12-23

Review 10.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.